GCIA
XENT

Gabelli & Co Investment Advisers’s Intersect ENT, Inc XENT Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-153,299
Closed -$4.29M – 549
2022
Q1 		$4.29M Buy
153,299
+33,286
+28% +$912K 0.56% 47
2021
Q4 		$3.28M Buy
120,013
+31,882
+36% +$864K 0.43% 43
2021
Q3 		$2.4M Buy
+88,131
New +$2.18M 0.29% 66
2020
Q4 		– Sell
-16,900
Closed -$276K – 352
2020
Q3 		$276K Buy
+16,900
New +$306K 0.05% 154

Gabelli & Co Investment Advisers's XENT Position: Q2 2022 in Review

Gabelli & Co Investment Advisers sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 153,299 shares — an estimated $4.29M sold.

Gabelli & Co Investment Advisers first reported a position in XENT in Q3 2020 and held it in 4 quarters. The position peaked at $4.29M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Gabelli & Co Investment Advisers reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 153,299 Intersect ENT, Inc shares in Q2 2022, an estimated $4.29M.
  • Gabelli & Co Investment Advisers first reported a position in Intersect ENT, Inc in Q3 2020 and held it in 4 quarters.
  • Gabelli & Co Investment Advisers's Intersect ENT, Inc position peaked at $4.29M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.